These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26922941)

  • 1. Quality of life utility values for hereditary haemochromatosis in Australia.
    de Graaff B; Neil A; Sanderson K; Yee KC; Palmer AJ
    Health Qual Life Outcomes; 2016 Feb; 14():31. PubMed ID: 26922941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis.
    de Graaff B; Neil A; Sanderson K; Si L; Yee KC; Palmer AJ
    Appl Health Econ Health Policy; 2015 Oct; 13(5):469-83. PubMed ID: 26255179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.
    de Graaff B; Neil A; Sanderson K; Yee KC; Palmer AJ
    Aust Health Rev; 2017 Jul; 41(3):254-267. PubMed ID: 27444148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persons with screening-detected haemochromatosis: as healthy as the general population?
    Asberg A; Hveem K; Krüger O; Bjerve KS
    Scand J Gastroenterol; 2002 Jun; 37(6):719-24. PubMed ID: 12126253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument.
    Richardson J; Iezzi A; Peacock S; Sinha K; Khan M; Misajon R; Keeffe J
    Ophthalmic Epidemiol; 2012 Jun; 19(3):172-82. PubMed ID: 22568431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage.
    Shaheen NJ; Lawrence LB; Bacon BR; Barton JC; Barton NH; Galanko J; Martin CF; Burnett CK; Sandler RS
    Am J Gastroenterol; 2003 May; 98(5):1175-80. PubMed ID: 12809845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Related Quality of Life in People Living with Psychotic Illness and Factors Associated with Its Variation.
    Neil AL; Carr VJ; Mackinnon A; Foley DL; Morgan VA
    Value Health; 2018 Aug; 21(8):1002-1009. PubMed ID: 30098664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia.
    de Graaff B; Neil A; Si L; Yee KC; Sanderson K; Gurrin L; Palmer AJ
    Appl Health Econ Health Policy; 2017 Aug; 15(4):521-534. PubMed ID: 28035629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utility values of high prevalence mental disorders in Australia: results from the National Survey of Mental Health and Wellbeing.
    Mihalopoulos C; Engel L; Le LK; Magnus A; Harris M; Chatterton ML
    Qual Life Res; 2018 Jul; 27(7):1815-1825. PubMed ID: 29633165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
    Ahmad H; Taylor BV; van der Mei I; Colman S; O'Leary BA; Breslin M; Palmer AJ
    Mult Scler; 2017 Jul; 23(8):1157-1166. PubMed ID: 27698247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model.
    de Graaff B; Si L; Neil AL; Yee KC; Sanderson K; Gurrin LC; Palmer AJ
    Pharmacoecon Open; 2017 Mar; 1(1):37-51. PubMed ID: 29442300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping oral health related quality of life to generic health state values.
    Brennan DS; Spencer AJ
    BMC Health Serv Res; 2006 Aug; 6():96. PubMed ID: 16893470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain quality of life as measured by utilities.
    Wetherington S; Delong L; Kini S; Veledar E; Schaufele MK; McKenzie-Brown AM; Chen SC
    Pain Med; 2014 May; 15(5):865-70. PubMed ID: 24716656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key-interventions derived from three evidence based guidelines for management and follow-up of patients with HFE haemochromatosis.
    Vanclooster A; Wollersheim H; Vanhaecht K; Swinkels D; Aertgeerts B; Cassiman D;
    BMC Health Serv Res; 2016 Oct; 16(1):573. PubMed ID: 27733158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
    Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
    Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
    Mohiuddin S; Payne K
    Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument.
    Hawthorne G
    Value Health; 2009 Sep; 12(6):948-57. PubMed ID: 19490558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.